PDA Technical Report No. 41: Virus filtration — 臺北醫學大學 跳至主導覽 跳至搜尋 跳過主要
內容 臺北醫學大學 首頁 臺北醫學大學 Logo 說明與常見問題 English 中文 首頁 專家檔案 研究 …

To protect against virus infections, the new technology of the virus removal membrane has
been developed. The novel virus removal filter PLANOVA is validated for virus removal, that …

Virus safety of biotech-and plasma-derived therapeutics is ensured through complementary
manufacturing and quality control measures that include the control and monitoring of raw …

Single-Use Virus Clearance Technologies in Biopharmaceutical Manufacturing: Case
Studies Page 1 Single-Use Virus Clearance Technologies in Biopharmaceutical …

Freedom from viral contaminants is a paramount concern for recombinant
biopharmaceuticals and plasma-derived medicinal products. Viral safety is achieved by a …

Retentive filters designed to provide effective and consistent clearance of parvovirus (∼ 20
nm) have now become a standard in downstream purification processes for biologics …

The viral safety of biotechnology products has traditionally been a key concern both of
regulators and industry. 1-6 It has also proven to be a stumbling block for early product …

The 2009 Viral Clearance Symposium (Indianapolis, IN, USA) was held to interactively
discuss methods for virus removal and inactivation during biopharmaceutical manufacture …

Filtration to remove viruses is one of the single most expensive steps in the production of
mAb drug products. Therefore, virus filtration steps should be fully optimized, and any …

Virus filtration is a crucial step in ensuring the high levels of viral clearance required in the
production of biotherapeutics produced in mammalian cells or derived from human plasma …